... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...  |  read more...

... characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. ...  |  read more...

... in the areas related to drug R&D, which makes each country unique for certain types of drug R&D outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India ...  |  read more...

... drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, patent expiry of popular blockbuster drugs, increase in disposable income and introduction ...  |  read more...

... analyses major bio-pharmaceutical market segments, top therapeutic categories and traditional medicine market (herbal drugs, ayurvedic and homeopathy). Report also include SWOT analysis, major driving forces, industry growth barriers, Opportunities, Regulatory structure, Macro economy factors and ...  |  read more...

... clinical studies. India has registered fast growth in the number of clinical trials over the past few years, reflecting that the country has become one of the most attractive destinations for medical research. According to ...  |  read more...

... people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn't stopped companies from investing in Asian vaccine markets. The graying of ...  |  read more...

... (or recruitment challenges) that plague studies in North America and Western Europe, unparalleled access to untapped patient populations, and new opportunities to meet the growing medical needs of these countries. Despite vast promise as the ...  |  read more...

... of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectable in India. The study ...  |  read more...

... toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 22 suppliers, representative of those active in this market. Segments covered in this report include: Chemistry Services Building ...  |  read more...

... Gaining Momentum with Increasing Pressure on Cost Cutting.” It provides key data, information and analysis of the major trends and issues affecting the drug discovery market in India and China. The report provides a comprehensive ...  |  read more...

... They are now forced to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in R&D or manufacturing. The keys for them to make a quick turnaround are to get drug discovered ...  |  read more...

... that the current business models have become both economically unsustainable and operationally unsuited to act quickly enough to produce the types of innovative treatments that will be demanded by global markets. Major issues confronting both ...  |  read more...